Clover Health to Report Second Quarter 2024 Financial Results on August 5
Clover Health Investments, Corp. (Nasdaq: CLOV) has announced it will release its second quarter 2024 financial results on Monday, August 5, 2024, after the market closes. The company will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day to discuss the results and business performance.
Interested parties can access the call by dialing 800-245-3047 (U.S. callers) or 203-518-9765 (international callers) using the conference ID: CLOVQ224. A live and archived webcast will be available on Clover Health's Investor Relations website for 12 months following the call.
Clover Health Investments, Corp. (Nasdaq: CLOV) ha annunciato che rilascerà i suoi risultati finanziari per il secondo trimestre del 2024 il lunedì 5 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conference call e una presentazione in streaming alle 17:00 ora orientale dello stesso giorno per discutere i risultati e le performance aziendali.
Le parti interessate possono partecipare alla call componendo il numero 800-245-3047 (per i chiamanti negli Stati Uniti) oppure 203-518-9765 (per i chiamanti internazionali) utilizzando l'ID conferenza: CLOVQ224. Sarà disponibile una presentazione in streaming dal vivo e archiviata sul sito web delle Relazioni con gli Investitori di Clover Health per 12 mesi dopo la call.
Clover Health Investments, Corp. (Nasdaq: CLOV) ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el lunes 5 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una llamada de conferencia y una transmisión en línea a las 5:00 p.m. hora del Este el mismo día para discutir los resultados y el rendimiento empresarial.
Las partes interesadas pueden acceder a la llamada marcando el 800-245-3047 (llamantes de EE.UU.) o 203-518-9765 (llamantes internacionales) utilizando el ID de conferencia: CLOVQ224. Una transmisión en vivo y archivada estará disponible en el sitio web de Relaciones con Inversores de Clover Health durante 12 meses después de la llamada.
Clover Health Investments, Corp. (Nasdaq: CLOV)는 2024년 2분기 재무 결과를 2024년 8월 5일 월요일, 시장 마감 후에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오후 5시에 회의 전화 및 웹캐스트를 개최하여 결과 및 비즈니스 성과를 논의할 예정입니다.
관심 있는 분들은 800-245-3047 (미국 전화 고객) 또는 203-518-9765 (국제 전화 고객)로 전화하여 회의 ID CLOVQ224를 사용하여 전화에 접속할 수 있습니다. 라이브 및 아카이브된 웹캐스트는 호출 후 12개월 동안 Clover Health의 투자자 관계 웹사이트에서 제공될 것입니다.
Clover Health Investments, Corp. (Nasdaq: CLOV) a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le lundi 5 août 2024, après la clôture des marchés. L'entreprise organisera un appel conférence et un webinaire à 17h00 heure de l'Est le même jour pour discuter des résultats et des performances commerciales.
Les parties intéressées peuvent accéder à l'appel en composant le 800-245-3047 (pour les appelants des États-Unis) ou le 203-518-9765 (pour les appelants internationaux) en utilisant l'ID de conférence : CLOVQ224. Un webinaire en direct et archivé sera disponible sur le site Web des relations avec les investisseurs de Clover Health pendant 12 mois après l'appel.
Clover Health Investments, Corp. (Nasdaq: CLOV) hat bekannt gegeben, dass das Unternehmen seine finanziellen Ergebnisse für das zweite Quartal 2024 am Montag, den 5. August 2024, nach Börsenschluss veröffentlichen wird. Am selben Tag wird das Unternehmen um 17:00 Uhr Eastern Time eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse und die Unternehmensleistung zu besprechen.
Interessierte können an der Konferenz teilnehmen, indem sie 800-245-3047 (US-Anrufer) oder 203-518-9765 (internationale Anrufer) wählen und die Konferenz-ID: CLOVQ224 verwenden. Ein Live- und Archiv-Webcast wird 12 Monate lang auf der Investor Relations-Website von Clover Health verfügbar sein.
- None.
- None.
FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2024 financial results after market close on Monday, August 5, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on August 5, 2024, to discuss Clover Health’s business and financial results.
Second Quarter 2024 Conference Call and Webcast Details:
- What: Clover Health’s Second Quarter 2024 Earnings Conference Call
- When: Monday, August 5, 2024, at 5:00 p.m. Eastern Time
- Dial In: To access the call via telephone please dial 800-245-3047 (for U.S. callers) or 203-518-9765 (for callers outside the U.S.) and enter the conference ID: CLOVQ224
- Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
FAQ
When will Clover Health (CLOV) report its Q2 2024 financial results?
What time is Clover Health's (CLOV) Q2 2024 earnings conference call?
How can I access Clover Health's (CLOV) Q2 2024 earnings call?
Where can I find the webcast for Clover Health's (CLOV) Q2 2024 earnings call?
